News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Yale Co-Leads New National Consortium for Rare Skin Disorders
October 12, 2026 - Grantee/Partner News
- Our Impact on Rare Diseases
- Rare Diseases Clinical Research Network (RDCRN)
A Technology Development Center Uses Human-Based Models to Discover Potential Treatments for Fibrotic Diseases
October 9, 2026 - NCATS News
- 3-D Tissue Bioprinting
A multi-institute collaboration, including NCATS, is using human-based 3-D models, drug screening and AI to study fibrotic diseases and accelerate the identification of potential safe and efficacious treatments.
Read ArticleFaster Chemical Reactions Made Possible by Tiny Droplets
June 1, 2026 - Grantee/Partner News
- ASPIRE
People With Chronic Back Pain May Be More Sensitive to Unpleasant Sounds
May 26, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Study finds people with chronic back pain may be more sensitive to unpleasant sounds, revealing sensory amplification that may be treatable.
FDA Clears IND for Gene Therapy Candidate to Treat Rare Metabolic Disorder
May 21, 2026 - NCATS News
- Our Impact on Clinical Trials
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
MMA-101, an NIH-supported AAV gene therapy for a rare metabolic disorder, has received FDA clearance to begin clinical testing.
Brain Regions React to Processed Diets in Unique Ways
May 21, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that older rats that ate low-fiber, highly processed diets experienced brain inflammation and memory problems.
NIH awards $50 million to UMass Center for Clinical and Translational Science
May 20, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Drug Combo is the First to Prolong Ketamine’s Antisuicide Effects
May 18, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program